Position in NPCE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,468,130
+$733,276 QoQ
Shares Held
344,124
-4.4% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#14
of 112 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $389,929,701 across 26 Medical Devices names. NPCE ranks #15 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
940,395 | $85,331,442 | |
| 2 | SYK |
Stryker Corp
|
182,236 | $57,375,182 | |
| 3 | HAE |
Haemonetics Corp
|
493,796 | $37,034,700 | |
| 4 | ITGR |
Integer Holdings Corp
|
371,484 | $34,715,179 | |
| 5 | AORT |
Artivion, Inc.
|
1,024,091 | $23,011,324 | |
| 6 | BSX |
Boston Scientific Corp
|
461,588 | $19,700,575 | |
| 7 | SIBN |
SI-BONE, Inc.
|
1,158,576 | $18,907,960 | |
| 8 | GKOS |
GLAUKOS Corp
|
121,880 | $17,033,948 |
All Filings in NPCE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,468,130 | 344,124 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,734,854 | 360,065 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,123,797 | 396,619 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,086,679 | 299,387 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,328,030 | 298,746 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,119,239 | 416,537 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||